SCHEMBL180238

SCHEMBL180238

CCCCCCC(CC)(C(=O)O)C(CC)CCCCCCC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.51
FFAR1 O14842 3/20 0.51
GPR84 Q9NQS5 7/20 0.49
PPARG P37231 7/20 0.49
PPARD Q03181 7/20 0.49
PPARA Q07869 7/20 0.49
HDAC11 Q96DB2 5/20 0.49
TSHR P16473 4/20 0.49
PTPN1 P18031 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TLR2 O60603 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
FABP4 P15090 2/20 0.49
KMT2A Q03164 2/20 0.49
SLC22A6 Q4U2R8 1/20 0.49
SLC22A8 Q8TCC7 1/20 0.49
MEN1 O00255 1/20 0.49
ESR1 P03372 1/20 0.49
ALOX15 P16050 1/20 0.49
PDE4A P27815 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11596358 1.00 FFAR4 (0.51) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998688 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998410 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998617 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL14809738 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998494 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL28816661 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL27998481 0.94 FFAR4 (0.54) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL29218960 0.93 GPR84 (0.42) FFAR4FFAR1GPR84PPARDMAPT
SCHEMBL17688068 0.91 GPR84 (0.43) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568640-B1 SUNSCREEN COMPOSITION DSM IP ASSETS BV (NL) 2026-05-13 EP claimed
EP-4552871-B1 SYSTEM AND METHOD FOR TESTING A CABIN AIR QUALITY COMPONENT OF A VEHICLE VOLVO CAR CORP (SE) 2026-03-25 EP claimed
US-20250153536-A1 SYSTEM AND METHOD FOR TESTING A CABIN AIR QUALITY COMPONENT OF A VEHICLE VOLVO CAR CORPORATION (SE) 2025-05-15 US claimed
EP-4552871-A1 SYSTEM AND METHOD FOR TESTING A CABIN AIR QUALITY COMPONENT OF A VEHICLE Volvo Car Corporation (SE) 2025-05-14 EP claimed
EP-4553480-A1 ASSEMBLY AND METHOD FOR TESTING A CABIN AIR QUALITY COMPONENT OF A VEHICLE Volvo Car Corporation (SE) 2025-05-14 EP claimed
EP-4362884-B1 A HYDRATABLE CONCENTRATED SURFACTANT COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2025-04-02 EP claimed
WO-2025032040-A1 MULTI-LAYER FILTER MEDIUM HENGST SE (DE) 2025-02-13 WO claimed
US-20240115981-A1 Biodegradable cellulose-based filter media and facial masks including the same AHLSTROM OYJ (FI) 2024-04-11 US claimed
EP-3612182-B1 RUPATADINE-CONTAINING PATCH TEIKOKU SEIYAKU KK (JP) 2024-01-10 EP claimed
EP-4288179-A1 BIODEGRADABLE CELLULOSE-BASED FILTER MEDIA AND FACIAL MASKS INCLUDING THE SAME Ahlstrom Oyj (FI) 2023-12-13 EP claimed
EP-2324812-A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients Sol-Gel Technologies Ltd. (IL) 2011-05-25 EP claimed
US-20050037087-A1 Compositions containing oils having a specific gravity higher than the specific gravity of water SOL-GEL TECHNOLOGIES LTD. (IL) 2005-02-17 US claimed
EP-1446086-A1 COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER Sol-Gel Technologies Ltd. (IL) 2004-08-18 EP claimed
JP-2003534249-A 2003-11-18 JP claimed
EP-1335693-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS Sol-Gel Technologies Ltd. (IL) 2003-08-20 EP claimed
WO-2003039510-A1 COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER SOL-GEL TECHNOLOGIES LTD. (IL) 2003-05-15 WO claimed
WO-2003034979-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS SOL-GEL TECHNOLOGIES LTD. (IL) 2003-05-01 WO claimed
US-20020064541-A1 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients SOL-GEL TECHNOLOGIES LTD. (IL) 2002-05-30 US claimed
WO-2001080823-A2 COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TROPICAL ACTIVE INGREDIENTS SOL-GEL TECHNOLOGIES LTD. (IL) 2001-11-01 WO claimed
EP-0620918-B1 CARBON DIOXIDE DETECTOR JOHNSON & JOHNSON PROFESSIONAL (GB) 1997-07-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037087-A1 Compositions containing oils having a specific gravity higher than the specific gravity of water GNG2, COG5, SQLE FFAR4 1993/4885FFAR1 1308/4885GPR84 129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.